A novel prognostic six‐CpG signature in glioblastomas

AIMS: We aimed to identify a clinically useful biomarker using DNA methylation‐based information to optimize individual treatment of patients with glioblastoma (GBM). METHODS: A six‐CpG panel was identified by incorporating genome‐wide DNA methylation data and clinical information of three distinct...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:CNS Neurosci Ther
Autores principales: Yin, An‐An, Lu, Nan, Etcheverry, Amandine, Aubry, Marc, Barnholtz‐Sloan, Jill, Zhang, Lu‐Hua, Mosser, Jean, Zhang, Wei, Zhang, Xiang, Liu, Yu‐He, He, Ya‐Long
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6489960/
https://ncbi.nlm.nih.gov/pubmed/29350455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12786
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares